Island -
islandsk -
LYFJASTOFNUN (Icelandic Medicines Agency)
addex-magnesium innrennslisþykkni, lausn 1 mmól/ml
fresenius kabi ab - magnesii sulfas - innrennslisþykkni, lausn - 1 mmól/ml
Den europeiske union -
islandsk -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Island -
islandsk -
LYFJASTOFNUN (Icelandic Medicines Agency)
oxaliplatin actavis innrennslisþykkni, lausn 5 mg/ml
actavis group ptc ehf. - oxaliplatinum inn - innrennslisþykkni, lausn - 5 mg/ml
Island -
islandsk -
LYFJASTOFNUN (Icelandic Medicines Agency)
fomepizole serb (fomepizole eusa pharma) innrennslisþykkni, lausn 5 mg/ml
serb s.a. - fomepizolum súlfat - innrennslisþykkni, lausn - 5 mg/ml
Island -
islandsk -
LYFJASTOFNUN (Icelandic Medicines Agency)
oxynorm stungulyfs-/innrennslisþykkni, lausn 10 mg/ml
mundipharma a/s - oxycodonum hýdróklóríð - stungulyfs-/innrennslisþykkni, lausn - 10 mg/ml
Den europeiske union -
islandsk -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - taugakerfi - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Den europeiske union -
islandsk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
islandsk -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
islandsk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Island -
islandsk -
LYFJASTOFNUN (Icelandic Medicines Agency)
sugammadex hameln stungulyf, lausn 100 mg/ml
hameln pharma gmbh - sugammadex sodium - stungulyf, lausn - 100 mg/ml